IndietroAutonomic Control of the Heart: Cardiac Physiology Study Guide
Guida di studio - Note intelligenti
Appunti personalizzati basati sui tuoi materiali, ampliati con definizioni chiave, esempi e contesto.
Autonomic Control of the Heart
Overview of Cardiac Autonomic Regulation
The heart possesses intrinsic mechanisms for generating its own rhythm, but the autonomic nervous system (ANS) modulates cardiac activity to meet the body's changing needs. The effects of autonomic input depend on the neurotransmitter released, the receptor activated, and the specific cardiac tissue targeted.
Intrinsic Cardiac Activity: The heart can generate rhythmic activity without nervous input, thanks to pacemaker cells (primarily in the SA node).
Autonomic Modulation: The ANS adjusts heart rate, contractile force, and conduction velocity to respond to physiological demands.
Autonomic Nervous System Pathways to the Heart
The ANS consists of two main divisions: sympathetic and parasympathetic. Both divisions use a two-neuron pathway to reach cardiac targets.
CNS: Integrates information and initiates autonomic output.
Preganglionic Neuron: Cell body in the CNS; axon projects to an autonomic ganglion.
Autonomic Ganglion: Relay station containing postganglionic neuron cell bodies.
Postganglionic Neuron: Axon projects from ganglion to cardiac tissue.
Cardiac Targets: Pacemaker tissue (SA node), conduction tissue (AV node), contractile myocardium.
Sympathetic vs. Parasympathetic Effects on the Heart
The sympathetic and parasympathetic divisions exert opposing effects on cardiac function, mediated by distinct neurotransmitters and receptors.
Sympathetic Division:
Prepares the body for increased activity ("fight or flight").
Increases heart rate, ventricular contractility, and AV nodal conduction.
Preganglionic neurons release acetylcholine (ACh) at the ganglion; ACh binds to nicotinic receptors on postganglionic neurons.
Postganglionic neurons release norepinephrine (NE) at cardiac targets; NE acts on β1-adrenergic receptors.
Parasympathetic Division:
Promotes "rest and digest" functions.
Slows heart rate and AV nodal conduction; minimal direct effect on ventricular contractility.
Preganglionic neurons release ACh at the ganglion; ACh binds to nicotinic receptors on postganglionic neurons.
Postganglionic neurons release ACh at cardiac targets; ACh acts on muscarinic (M2) receptors.
Neurotransmitters and Receptors: Cardiac Effects
Division | Preganglionic Neurotransmitter | Ganglionic Receptor | Postganglionic Neurotransmitter | Cardiac Target Receptor | Main Cardiac Effects |
|---|---|---|---|---|---|
Sympathetic | ACh | Nicotinic | NE | β1-adrenergic | ↑ Heart rate, ↑ Contractility, ↑ AV conduction |
Parasympathetic | ACh | Nicotinic | ACh | Muscarinic (M2) | ↓ Heart rate, ↓ AV conduction, minimal ↓ Contractility |
Functional Effects: Chronotropy, Inotropy, Dromotropy
Three key terms describe the functional effects of autonomic input on the heart:
Chronotropy (Rate):
Refers to the rate of cardiac activity, especially heart rate.
Positive chronotropic effect: Increases heart rate (e.g., sympathetic stimulation).
Negative chronotropic effect: Decreases heart rate (e.g., parasympathetic stimulation).
The SA node is central to chronotropic effects.
Inotropy (Force):
Refers to the force of cardiac contraction.
Positive inotropic effect: Increases contractile force (e.g., sympathetic stimulation).
Negative inotropic effect: Decreases contractile force.
Sympathetic stimulation strongly increases ventricular contractility; parasympathetic effect is minimal.
Dromotropy (Conduction):
Refers to the speed of electrical conduction through cardiac tissue, especially the AV node.
Positive dromotropic effect: Increases conduction velocity (e.g., sympathetic stimulation).
Negative dromotropic effect: Decreases conduction velocity (e.g., parasympathetic stimulation).
The AV node delays transmission from atria to ventricles; autonomic input can alter this timing.
Example: Increased Vagal Activity
Increased vagal (parasympathetic) activity leads to decreased heart rate and slowed AV nodal conduction. The pathway involves:
Preganglionic neuron releases ACh at the ganglion (activates nicotinic receptors).
Postganglionic neuron releases ACh at cardiac targets (activates M2 muscarinic receptors).
Functional effects: Negative chronotropic (↓ heart rate) and negative dromotropic (↓ AV conduction).
Common Misconceptions and Clarifications
Intrinsic vs. Extrinsic Control: The heart's pacemaker cells generate rhythm independently; the ANS modulates, but does not initiate, each beat.
ACh Effects: Both divisions use ACh at ganglia, but effects differ due to receptor types and target tissues.
Sympathetic Effects: Sympathetic activity affects rate, contractility, and conduction—not just heart rate.
Parasympathetic Effects: Parasympathetic activity slows the heart but does not stop it.
Terminology: Chronotropy, inotropy, and dromotropy refer to distinct physiological variables.
AV Node vs. SA Node: Slower AV conduction does not mean slower SA node pacing.
Neurotransmitter Effects: The effect depends on receptor type and target tissue, not just the neurotransmitter.
Practice Questions
Which neurotransmitter is released by both sympathetic and parasympathetic preganglionic neurons? Answer: Acetylcholine (ACh)
Which receptor is activated by NE in the typical sympathetic pathway to the heart? Answer: β1-adrenergic receptor
Which receptor is activated by ACh released from parasympathetic postganglionic neurons at cardiac targets? Answer: Muscarinic (M2) receptor
Define chronotropy, inotropy, and dromotropy. Answer: Chronotropy: heart rate; Inotropy: contractile force; Dromotropy: conduction velocity
A drug increases activation of cardiac β1 receptors. Predict the typical effects on heart rate, ventricular contractility, and AV nodal conduction. Answer: Increased heart rate, increased contractility, increased AV conduction
Increased vagal activity slows heart rate. Identify the postganglionic neurotransmitter and receptor responsible for the typical cardiac response. Answer: ACh (neurotransmitter), M2 muscarinic receptor
A student claims that parasympathetic activity should increase heart rate because ACh is released by both autonomic divisions at their ganglia. Identify the reasoning error. Answer: The effect depends on the receptor and target tissue, not just the neurotransmitter.
An experimental intervention slows AV nodal conduction without directly changing SA nodal pacing. Which functional effect has changed, and which has not necessarily changed? Answer: Dromotropy (conduction) has changed; chronotropy (rate) has not necessarily changed.
A hypothetical drug blocks M2 receptors in the heart. Predict how this would affect the ability of parasympathetic activity to slow heart rate. Answer: Parasympathetic activity would be unable to slow heart rate effectively.
A patient has increased sympathetic activity. Explain why “the heart beats faster” is an incomplete description of the possible cardiac response. Answer: Sympathetic activity also increases contractile force and AV nodal conduction, not just heart rate.
Summary Table: Autonomic Effects on Cardiac Function
Effect | Sympathetic | Parasympathetic |
|---|---|---|
Chronotropy (Rate) | ↑ (Positive) | ↓ (Negative) |
Inotropy (Force) | ↑ (Positive) | Minimal ↓ (Negative) |
Dromotropy (Conduction) | ↑ (Positive) | ↓ (Negative) |
Key Equations and Concepts
Cardiac Output: The amount of blood pumped by the heart per minute.
Autonomic Modulation: Changes in heart rate (chronotropy), contractility (inotropy), and conduction (dromotropy) alter cardiac output and overall cardiovascular function.
Additional info: The vagus nerve is responsible for approximately 75% of parasympathetic activity to the heart. The SA node sets the pace of the heartbeat, while the AV node regulates conduction between atria and ventricles. The effect of neurotransmitters depends on the receptor type and the specific cardiac tissue targeted.